Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Biotechnology Development Fund VI
AddedMar 20, 2024
UpdatedJun 28, 2026
Biotechnology Development Fund VI

Biotechnology Development Fund VI

Operating

Palo Alto financial services firm investing in biotech and healthcare companies.

Location
Palo Alto, CA, US
Founded
2003
Firm
Compare
Portfolio
Employees

Biotechnology Development Fund IV, L.P. specializes in late venture investments. It seeks to invest in biotechnology, pharmaceutical, therapeutic devices, medical device and health care information technology companies. In addition to making direct equity investments in portfolio companies, it may invest in or form entities that will attempt to secure rights to develop, manufacture, and market company products in selected Asian markets.

The majority of the investments are in United States based companies with approved products or products in mid- to late-stage development. However, investments may also be made in early-stage companies with compelling platform technology and/or business stra...

Biotechnology Development Fund VI - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments1
Current Portfolio Count1
Total Portfolio Exits0

Top Investment Stages

Series Unknown1 (100.0%)

Stage Mix

Series Unknown 100%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Copernicus Therapeutics logo

Copernicus Therapeutics

Similar Investment Firms

Acorn Bioventures logo

Acorn Bioventures

Biotechnology Value Fund logo

Biotechnology Value Fund

bvflp.com

BioImpact Capital logo

BioImpact Capital

Amicus Capital Partners logo

Amicus Capital Partners

Beta Fund logo

Beta Fund

Devon Park Bioventures logo

Devon Park Bioventures

Bioventures Investors logo

Bioventures Investors

BioVenture logo

BioVenture

bioventure.com.cn

Biotech Insight Ventures logo

Biotech Insight Ventures

Bios Partners logo

Bios Partners

biospartners.com

Aditum Bio logo

Aditum Bio

aditumbio.com

BioRock Ventures logo

BioRock Ventures

Inbio Ventures logo

Inbio Ventures

venBio Partners logo

venBio Partners

venbio.com

Biocapx logo

Biocapx

Biotechnology Development Fund VI - Classification

Also Known As
  • Biotechnology Development Fund VI, L.P.
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end
Show 2 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
SIC
  • 6000Depository Institutions